Immunosuppressive therapy in liver transplantation: contribution to nursing
DOI:
https://doi.org/10.13037/ras.vol14n50.3992Keywords:
liver transplantation, immunosuppressive agents, nursingAbstract
Introduction: All patients undergoing liver transplantation require lifelong treatment with immunosuppressive agents in order to avoid graft rejection. Objective: This study aims to characterize the immunosuppressive therapy used in liver transplantation and propose nursing interventions to manage this therapeutic group. Method: This is a documental, bibliographical and descriptive research conducted from clinical protocols of liver transplantation from the transplant centers of Ceará, Brazil. From the protocols, the immunosuppressive agents used in liver transplantation were identified and then characterized about its clinical and pharmacological characteristics from the specialized and current literature in the field of medicine and pharmacology. It then proceeded with the discussion about the proper management of this therapy by the nursing team from the evidences of Micromedex and UpToDate bases. Results: Immunosuppressive agents have specific characteristics related to their indications, mechanisms of action, adverse effects and drug interactions, in which knowing and understanding these characteristics are fundamental to the management of the therapy aiming to an adequate graft function. In this scenario, the nursing team has responsibility not only in the administration of immunosuppressive agents, but also in monitoring the results, preventing complications and promoting health education for patients and families. Conclusions: The management of immunosuppressive agents requires nursing professionals scientifically grounded about the characteristics and related care in order to ensure a safe and effective therapy, as in to support the patient with relevant guidelines, thus ensuring their empowerment in the process of self-care.
Downloads
References
Moini M, Schilsky ML, Tichy EM. Review on immunosuppression in liver transplantation. World J Hepatol. 2015;7(10):1355-68.
Meirelles Júnior RF, Salvalaggio P, Rezende MB, Evangelista AS, Guardia BD, Matielo CE, et al. Transplante de fígado: história, resultados e perspectivas. Einstein. 2015;13(1):149-52.
Mendes KDS, Rossin FM, Ziviani LC, Castro-e-Silva O, Galvão CM. Necessidades de informação de candidatos ao transplante de fígado: o primeiro passo do processo ensino-aprendizagem. Rev Gaucha Enferm. 2012;33(4):94-102.
Associação Brasileira de Transplante de Órgãos (BR); Registro Brasileiro de Transplantes. Dimensionamento dos transplantes no Brasil e em cada estado. São Paulo: Associação Brasileira de Transplante de Órgãos, 2014.
Kern B, Sucher R. Clinical immunosuppression in solid organ and composite tissue allotransplantation. In: Kapur S, Portela MB, editors. Immunosuppression – role in health and diseases. [s.l.]: InTech; 2012. p. 423-32.
Jara P. Inmunosupresión en niños con trasplante hepático. Rev Gastrohnup. 2010;12(2) Suppl 1:S31-7.
Wang C, Wang G, Yi H, Tan J, Xu C, Fang X, et al. Symptom experienced three years after liver transplantation under immunosuppression in adults. PLoS One. 2013;8(11):1-9.
Silva LR, Martins TSS, Silvino ZR, Mello LP, Castro MA, Andrade ENM. Reações adversas medicamentosas na unidade pediátrica: o conhecimento da equipe de enfermagem. Rev Rene. 2011;12(1):144-9.
Ministério da Saúde (BR); Secretaria de Ciência; Tecnologia e Insumos Estratégicos. Relação Nacional de Medicamentos Essenciais: RENAME 2014. Brasília: Ministério da Saúde; 2015.
Micromedex Healthcare Series [Internet]. Colorado: Greenwood Village; [citado em 2015 Set 29]. Disponível em: https://www.thomsonhc.com/
Wolters Kluwer Health. Uptodate [Internet]. [citado em 2015 Set 29]. Disponível em: https://www.uptodate.com/
Van Sandwijk MS, Bemelman FJ, Ten Berge IJM. Immunosuppressive drugs after solid organ transplantation. Neth J Med. 2013;71(6):281-9.
Rodríguez-Perálvarez M, De La Mata M, Burroughs AK. Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant. 2014;19(3):253-60.
Enderby C, Keller CA. An overview of immunosuppression in solid organ transplantation. Am J Manag Care. 2015;21 Suppl 1:S12-23.
Hardinger KL, Brennan DC. Novel immunosuppressive agents in kidney transplantation. World J Transplant. 2013;3(4):68-77.
Bressan AL, Souto RS, Fontenelle E, Gripp AC. Imunossupressores na dermatologia. An Bras Dermatol. 2010;85(1):9-22.
Martins TSS, Silvino ZR, Silva LR. Eventos adversos na terapia farmacológica pediátrica: revisão integrativa da literatura. Rev Bras Enferm. 2011;64(4):745-50.
Jacomini LCL, Silva NA. Interações medicamentosas: uma contribuição para o uso racional de imunossupressores sintéticos e biológicos. Rev Bras Reumatol. 2011;51(2):161-74.
Ministério da Saúde (BR); Secretaria de Vigilância em Saúde; Departamento de Vigilância das Doenças Transmissíveis. Manual de normas e procedimentos para vacinação. Brasília: Ministério da Saúde; 2014.
Jorge DBR, Popov DCS. Aspectos fundamentais da assistência de enfermagem no transplante hepático. Rev Enferm UNISA. 2011;12(2):142-7.
Mendes KDS, Castro e Silva O, Ziviani LC, Rossin FM, Zago MMF, Galvão CM. Intervenção educativa para candidatos ao transplante de fígado. Rev Latino-Am Enfermagem. 2013;21(1):7 telas.
Downloads
Published
Issue
Section
License
Policy Proposal for Journals offering Free Delayed Access
Authors who publish in this magazine agree to the following terms:
- Authors maintain the copyright and grant the journal the right to the first publication, with the work simultaneously licensed under a Creative Commons Attribution License after publication, allowing the sharing of the work with recognition of the authorship of the work and initial publication in this journal.
- Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this magazine (eg, publishing in institutional repository or as a book chapter), with the acknowledgment of the authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase impact and citation of the published work (See The Effect of Open Access).